NYSE:BHC

Bausch Health Companies Stock News

Healthcare > Drug Manufacturers - Specialty & Generic

Buy BHC

*Your capital is at risk

$4.95

-0.0600 (-1.20%)

At Close: Jun 03, 2026

Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

10:15am, Wednesday, 25'th Sep 2024

Bausch Health NYSE: BHC stock has been on a wild ride recently, with a dramatic surge in value over the last month. The catalyst for this surge is a wave of rumors suggesting that Bausch + Lomb NYSE:

Here's Why Bausch Health Stock Gained 14.7% in a Week

02:45pm, Monday, 23'rd Sep 2024

BHC stock rises 14.7% in a week after a report surfaced that the company is in talks with Jefferies Financial Group to push out maturities on some of its debt.

3 Stocks Billionaires Are Buying Now

12:00pm, Sunday, 22'nd Sep 2024

Tom Yeung here with your Sunday Digest. During the early 1990s real estate crisis, the Marriott Corp. hotel chain found itself in trouble.

Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely

04:51pm, Thursday, 19'th Sep 2024

Bausch Health's debt burden and potential bankruptcy risks are mitigated by the likely sale of Bausch + Lomb, which could fetch a premium price. Bausch + Lomb's stable business and the recent acquisit

Bausch (BHC) Surges 11.7%: Is This an Indication of Further Gains?

08:05am, Thursday, 19'th Sep 2024

Bausch (BHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

With Buyout Interest, Bausch + Lomb May Still Be Worth Interest At Current Levels

07:30am, Thursday, 19'th Sep 2024

Bausch + Lomb stock has rebounded since January, but still offers value, especially with potential takeover interest and a solid balance sheet. BLCO shares trade at a reasonable premium to forward ear

Op-ed: Here's why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors

12:22pm, Tuesday, 17'th Sep 2024

Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don't think like your typical corporate board, writes Ken Squire of 13D Monitor.

Bausch & Lomb reportedly exploring sale, shares rise

10:40am, Monday, 16'th Sep 2024

Bausch & Lomb stock surged on reports the American-Canadian eye health products firm is exploring a sale as it seeks to resolve issues related to its separation from its debt-laden parent company Baus

Bausch + Lomb's stock soars 18% on report company is considering selling itself

08:03am, Monday, 16'th Sep 2024

Eye-care company is working with Goldman Sachs on a deal that would extricate it from its indebted parent, the Financial Times reported.

Here's Why Bausch Health (BHC) is a Strong Momentum Stock

10:50am, Wednesday, 11'th Sep 2024

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Health Canada Approves (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Triple-Combination Topical Treatment for Acne Vulgaris in Patients 12 Years of Age and Older

07:00am, Wednesday, 11'th Sep 2024

LAVAL, QC / ACCESSWIRE / September 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the approval by Health Canada of PrCABTREOTM (clindam

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by